V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002644 | 210004007 | null | null | null | null | 2019-05-22 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101704040 |
| 210002788 | 210004011 | null | null | null | 2017-02-12 | 2017-02-12 | null | 02 | N | FEC + DOCETAXEL | 100834408 |
| 210001806 | 210005483 | 1.61 | 67.4 | Palliative (P) | 2017-12-23 | 2018-01-13 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100670176 |
| 210001808 | 210005485 | null | 100 | null | 2018-07-07 | 2018-07-14 | Docetaxel | null | null | DOCETAXEL | 100422168 |
| 210001809 | 210005486 | 1.64 | 78.3 | Adjuvant (A) | null | 2017-07-02 | Paclitaxel 7 day | null | N | PACLITAXEL | 100893021 |
| 210001812 | 210005488 | 1.69 | 66.4 | Adjuvant (A) | 2018-08-05 | 2018-08-24 | Docetaxel | null | N | DOCETAXEL | 100894587 |
| 210001813 | 210005489 | 1.58 | 63 | Neo-adjuvant (N) | 2016-07-15 | 2016-08-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100728056 |
| 210001814 | 210005490 | 1.72 | 91.7 | Adjuvant (A) | 2017-05-27 | 2017-10-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101129981 |
| 210001815 | 210005491 | 1.64 | 45.6 | Adjuvant (A) | null | 2020-02-14 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101649127 |
| 210001816 | 210005492 | 1.75 | 71 | Adjuvant (A) | 2016-10-31 | 2016-12-05 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101257310 |
| 210001817 | 210005493 | 1.56 | 0 | Palliative (P) | 2016-09-07 | 2016-09-29 | EC | 02 | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100277557 |
| 210001818 | 210005494 | null | 103.5 | null | null | 2019-04-11 | Docetaxel | 02 | null | DOCETAXEL | 101799932 |
| 210001819 | 210005495 | 1.66 | 71 | Neo-adjuvant (N) | 2017-10-18 | 2017-10-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100191042 |
| 210001820 | 210005496 | 1.65 | 55.4 | null | 2019-08-14 | 2019-08-21 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101072683 |
| 210001821 | 210005497 | 1.59 | 63.3 | Neo-adjuvant (N) | 2018-07-19 | 2018-07-24 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101461300 |
| 210001823 | 210005499 | 1.68 | 55.1 | null | 2017-05-12 | 2017-06-01 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100210455 |
| 210001824 | 210005500 | 1.54 | 85 | Adjuvant (A) | 2018-05-29 | 2018-05-31 | Docetaxel | 02 | N | DOCETAXEL | 100136808 |
| 210001825 | 210005501 | 1.77 | 94.6 | Adjuvant (A) | 2019-10-17 | 2019-10-17 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100972561 |
| 210001826 | 210005502 | 1.62 | 56.5 | Neo-adjuvant (N) | null | 2016-12-03 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100727036 |
| 210001828 | 210005503 | 1.6 | 80.6 | Palliative (P) | 2016-05-05 | 2016-05-05 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100405088 |
| 210001829 | 210005504 | 1.7 | 67.7 | Neo-adjuvant (N) | 2019-05-18 | 2019-06-02 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100307748 |
| 210001830 | 210005505 | 1.77 | 85.5 | Adjuvant (A) | 2017-01-28 | 2017-02-16 | Trastuzumab 21 day maintenance | null | N | TRASTUZUMAB | 101122586 |
| 210001835 | 210005507 | 1.6 | 70.8 | null | 2017-07-24 | 2017-07-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101304869 |
| 210001836 | 210005508 | null | null | null | 2020-06-21 | 2020-06-29 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100920908 |
| 210001837 | 210005509 | 1.75 | 68 | null | null | 2017-03-25 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100141422 |
| 210001838 | 210005510 | null | null | null | 2021-05-08 | 2021-05-26 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101658297 |
| 210001839 | 210005511 | 1.6 | 63.2 | Adjuvant (A) | null | 2017-06-07 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101622031 |
| 210001840 | 210005512 | 1.6 | 80.8 | Adjuvant (A) | null | 2018-09-12 | Trastuzumab 21 day maintenance | null | N | TRASTUZUMAB | 101357537 |
| 210001841 | 210005513 | 1.55 | 91 | Neo-adjuvant (N) | null | 2018-11-12 | Trastuzumab Subcutaneous | 2 | N | TRASTUZUMAB | 101520530 |
| 210001842 | 210005514 | 1.63 | 71.1 | Adjuvant (A) | null | 2018-08-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100444266 |
| 210001843 | 210005515 | 1.47 | 64.4 | null | null | 2016-08-23 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100424396 |
| 210001846 | 210005517 | 1.66 | 54 | Adjuvant (A) | 2016-10-21 | 2016-10-21 | Trastuzumab | 02 | N | TRASTUZUMAB | 100762294 |
| 210001847 | 210005518 | null | 102.5 | null | 2015-08-02 | 2016-11-28 | Docetaxel | 02 | null | DOCETAXEL | 100494884 |
| 210001849 | 210005520 | 1.65 | 74.9 | Adjuvant (A) | 2019-12-05 | 2019-12-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100344755 |
| 210001850 | 210005521 | 1.64 | 89.6 | Adjuvant (A) | 2017-01-23 | 2017-01-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101800772 |
| 210001851 | 210005522 | 1.58 | 85.2 | Neo-adjuvant (N) | 2016-04-15 | 2016-04-22 | PACLITAXEL | null | N | PACLITAXEL | 100722593 |
| 210001852 | 210005523 | 1.65 | 88.8 | Neo-adjuvant (N) | 2019-05-25 | 2019-05-26 | Docetaxel | 02 | N | DOCETAXEL | 101276608 |
| 210001853 | 210005524 | 1.61 | 72.4 | Neo-adjuvant (N) | null | 2019-01-23 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101129470 |
| 210001854 | 210005525 | null | 69 | null | 2017-05-06 | 2017-05-07 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101141974 |
| 210001855 | 210005526 | 1.62 | 67.4 | Palliative (P) | 2016-05-29 | 2016-06-18 | Docetaxel | null | N | DOCETAXEL | 101088188 |
| 210001856 | 210005527 | 1.55 | 72 | Adjuvant (A) | 2018-03-08 | 2018-03-13 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100149590 |
| 210001857 | 210005528 | 1.54 | 71.1 | Palliative (P) | null | 2019-10-03 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100179540 |
| 210001859 | 210005529 | 1.65 | 68.7 | Neo-adjuvant (N) | 2018-07-27 | 2018-07-28 | PACLITAXEL | 02 | N | PACLITAXEL | 101212315 |
| 210001862 | 210005531 | 0 | 79.1 | Adjuvant (A) | 2012-12-03 | 2012-12-25 | Docetaxel | 02 | N | DOCETAXEL | 101636747 |
| 210001863 | 210005532 | 1.62 | 81 | Palliative (P) | 2019-04-13 | 2019-05-04 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101014890 |
| 210001864 | 210005533 | 1.66 | 92.3 | Adjuvant (A) | 2018-08-06 | 2018-10-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 101063448 |
| 210001865 | 210005534 | 1.62 | 100 | Adjuvant (A) | 2018-09-07 | 2018-09-30 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100261467 |
| 210001866 | 210005535 | null | 85.8 | null | 2017-08-07 | 2017-08-15 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100645536 |
| 210001869 | 210005537 | 1.64 | 106.9 | Adjuvant (A) | 2018-06-03 | 2018-06-05 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101219752 |
| 210001870 | 210005538 | 1.51 | 73.6 | Adjuvant (A) | 2019-04-10 | 2019-06-25 | PACLITAXEL | 02 | N | PACLITAXEL | 100988767 |